Company / Operating Income per Share
Tandem Diabetes Care Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.83
FY2025
5-year range
-$3.62 / -$0.12
FY2021-FY2025
Trend
-86.9%
vs FY2024
Sector context
#141 of 154
Health Care
What the data says
Among 154 Health Care companies, Tandem Diabetes Care is in the bottom 8% for operating income per share. Operating Income per Share has fluctuated over the past 10 years, ranging from $-22.19 in FY2017 to $-0.12 in FY2022.
Based on SEC 10-K filings.
-2.83 in FY2025.
Improved from $-3.62 to $-2.83 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 154This company -$2.83 Sector average $4.29
▼
-165.9% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 86.9% year-over-year.
- Ranks #141 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.83 | -86.9% |
| FY2024 | -$1.51 | +58.2% |
| FY2023 | -$3.62 | -2800.2% |
| FY2022 | -$0.12 | +53.5% |
| FY2021 | -$0.27 | +64.3% |
| FY2020 | -$0.75 | +31.3% |
| FY2019 | -$1.09 | +85.8% |
| FY2018 | -$7.71 | +65.2% |
| FY2017 | -$22.19 | -760.1% |
| FY2016 | -$2.58 | +11.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026